Nutritional Treatment of Hypertriglyceridemia in Childhood: From Healthy-Heart Counselling to Life-Saving Diet
- PMID: 36904088
- PMCID: PMC10005617
- DOI: 10.3390/nu15051088
Nutritional Treatment of Hypertriglyceridemia in Childhood: From Healthy-Heart Counselling to Life-Saving Diet
Abstract
Hypertriglyceridemia is a lipid disorder with a varying prevalence; it is very common if we consider triglyceride plasma values slightly above the threshold, whereas it is extremely rare if only severely elevated triglyceride levels are considered. In most cases, severe forms of hypertriglyceridemia are caused by genetic mutations in the genes that regulate triglyceride metabolism, thus leading to extreme triglyceride plasma values and acute pancreatitis risk. Secondary forms of hypertriglyceridemia are usually less severe and are mainly associated with weight excess, but they can also be linked to liver, kidney, endocrinologic, or autoimmune diseases or to some class of drugs. Nutritional intervention is the milestone treatment for patients with hypertriglyceridemia and it has to be modulated on the underlying cause and on triglyceride plasma levels. In pediatric patients, nutritional intervention must be tailored according to specific age-related energy, growth and neurodevelopment requests. Nutritional intervention is extremely strict in case of severe hypertriglyceridemia, whereas it is similar to good healthy nutritional habits counselling for mild forms, mainly related to wrong habits and lifestyles, and to secondary causes. The aim of this narrative review is to define different nutritional intervention for various forms of hypertriglyceridemia in children and adolescents.
Keywords: childhood; hypertriglyceridemia; nutrition; overweight; pediatrics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Hypertriglyceridemia-Associated Pancreatitis: New Concepts and Potential Mechanisms.Clin Chem. 2023 Oct 3;69(10):1132-1144. doi: 10.1093/clinchem/hvad094. Clin Chem. 2023. PMID: 37530032
-
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief Report.Arterioscler Thromb Vasc Biol. 2022 Dec;42(12):1461-1467. doi: 10.1161/ATVBAHA.122.318445. Epub 2022 Nov 3. Arterioscler Thromb Vasc Biol. 2022. PMID: 36325899
-
Successful treatment of severe hypertriglyceridemia with a formula diet rich in omega-3 fatty acids and medium-chain triglycerides.Ann Nutr Metab. 2010;56(3):170-5. doi: 10.1159/000283561. Epub 2010 Feb 12. Ann Nutr Metab. 2010. PMID: 20150726
-
Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia.Curr Opin Lipidol. 2023 Apr 1;34(2):59-69. doi: 10.1097/MOL.0000000000000866. Epub 2023 Feb 1. Curr Opin Lipidol. 2023. PMID: 36752614 Free PMC article. Review.
-
Hypertriglyceridemia-Associated Drug-Induced Acute Pancreatitis.Pancreas. 2019 Jan;48(1):22-35. doi: 10.1097/MPA.0000000000001190. Pancreas. 2019. PMID: 30531242
Cited by
-
Non-Pharmacological Treatment for Cardiovascular Risk Prevention in Children and Adolescents with Obesity.Nutrients. 2024 Jul 31;16(15):2497. doi: 10.3390/nu16152497. Nutrients. 2024. PMID: 39125377 Free PMC article. Review.
-
Omega-3 supplementation and cardiometabolic risk factors in obese/overweight children and adolescents: a GRADE assessed systematic review and meta-analysis.Nutr Metab (Lond). 2025 Jul 17;22(1):78. doi: 10.1186/s12986-025-00952-x. Nutr Metab (Lond). 2025. PMID: 40676659 Free PMC article. Review.
-
Clinical and molecular spectrum of genetic hypertriglyceridaemia in North Indian children: a case series.Pediatr Endocrinol Diabetes Metab. 2025;31(1):25-29. doi: 10.5114/pedm.2025.148401. Pediatr Endocrinol Diabetes Metab. 2025. PMID: 40353385 Free PMC article.
-
Fiber in the Treatment of Dyslipidemia in Pediatric Patients.Children (Basel). 2025 Mar 28;12(4):427. doi: 10.3390/children12040427. Children (Basel). 2025. PMID: 40310063 Free PMC article. Review.
-
Long-Chain Polyunsaturated Fatty Acids Effects on Cardiovascular Risk in Childhood: A Narrative Review.Nutrients. 2023 Mar 29;15(7):1661. doi: 10.3390/nu15071661. Nutrients. 2023. PMID: 37049503 Free PMC article. Review.
References
-
- Virani S.S., Morris P.B., Agarwala A., Ballantyne C.M., Birtcher K.K., Kris-Etherton P.M., Ladden-Stirling A.B., Miller M., Orringer C.E., Stone N.J. Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypetriglyceridemia A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 2021;78:960–993. doi: 10.1016/j.jacc.2021.06.011. - DOI - PubMed
-
- Societies E.N.C., Mach F., Baigent C., Taskinen M.R. ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205. - PubMed
-
- Wiegman A., Gidding S.S., Watts G.F., Chapman M.J., Ginsberg H.N., Cuchel M., Ose L., Averna M., Boileau C., Borén J., et al. Familial hypercholesterolaemia in children and adolescents: Gaining decades of life by optimizing detection and treatment. Eur. Heart J. 2015;36:2425–2437. doi: 10.1093/eurheartj/ehv157. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical